Humanized antibodies against CD3

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

10435299

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention provides bispecific antibodies with selective cytotoxicity against malignant B-cells. The bispecific antibodies bind to an effector cell antigen and to a 28/32 kDa heterodimeric protein on the surface of malignant B-cells. The invention also includes the monospecific components of the bispecific antibodies, humanized versions thereof, and humanized bispecific antibodies. The invention further provides therapeutic and diagnostic methods employing these antibodies.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PDL BIOPHARMA INC34801 CAMPUS DRIVE FREMONT CA 94555

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gingrich, Roger Iowa City, IA 4 110
Link, Brian K Carlville, IA 4 110
Tso, J Yun Menlo Park, CA 71 1780
Weiner, George Iowa City, IA 18 782

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation